Evidence map›Paper›PMID 39459974›Full record

ArticleViruses2024

The HIV-1

Antonio Solis-Leal, Dalton C Karlinsey, Sidney T Sithole, Jack Brandon Lopez, Amanda Carlson, Vicente Planelles, Brian D Poole, Bradford K Berges

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The HIV-1 Vpr R77Q mutant alters host apoptotic gene regulation in CD4+ T cells.Frontiers in cellular and infection microbiology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Antonio Solis-LealDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA.ORCID 0000-0002-5063-3266
Dalton C KarlinseyDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA.ORCID 0009-0004-1786-905X
Sidney T SitholeDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA.
Jack Brandon LopezDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA.
Amanda CarlsonDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA.
Vicente PlanellesDepartment of Pathology, Division of Microbiology and Immunology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Brian D PooleDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA.ORCID 0000-0002-3205-640X
Bradford K BergesDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA.ORCID 0000-0003-0711-576X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acquired immunodeficiency syndrome (AIDS) occurs when HIV depletes CD4+ helper T cells. Some patients develop AIDS slowly or not at all, and are termed long-term non-progressors (LTNP), and while mutations in the HIV-1 Viral Protein R (

Indexed as

ApoptosisCD4-Positive T-LymphocytesCytokinesG2 Phase Cell Cycle CheckpointsHIV-1vpr Gene Products, Human Immunodeficiency VirusCell LineHIV InfectionsHumansMutationVirus ReplicationCytokinesvpr Gene Products, Human Immunodeficiency Virusvpr protein, Human immunodeficiency virus 1AIDSapoptosisHIVimmune activationinflammationnecrosisvpr

Identifiers

PMID39459974
PMCPMC11512211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.